Either way you look at it, I think it still proves that us retail investors that are in now are still invested early. Institutional investors invest in presentations, paper, timelines, ROI, etc...We are investing in technology that will be superior once to market. A product that has the ability to be sold into the largest hospitals, to the average community hospital, and to private surgical centers, will explode in sales. The US market is ready, and HUGE for SPORT!
We brought a product to market in 2013, into a category that had two other competitors. The two other competitors were small companies with inferior technology. These two other competitors had at least a two/three year head start. We took the market by storm and since have outsold our competitors 15 to 1. Why? We had the right product at the right time with the right technology. As much as I am disapointed about the recent drop in share price, having the right product makes selling easier and ultimately faster. Selling into the medical field is like anything else, once one set of customers (in our case surgeons) have something and they like it, word spreads fast. Once one set of docs have new technology and it sucks, word spreads fast negatively as well, probably faster. Then who is going to buy your product? No one. They are protecting the product, so for that I respect the decision. They do need to get this right this time around. When the institutional money wakes up, this thing will soar.
Happy Thanksgiving everyone!
News 
Market Data 
Discover 
